Table 4.

Unadjusted LVD-36 cross-comparison between all study subgroups (ns for p > 0.05, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001).

Number of patients in each group	LVD-36 score: mean ± SE	Groups	PAVF(+)	PAVF(−)	DAVF(+)	DAVF(−)	Controls
22	12.5 ± 3.12	Controls	***	*	ns	ns	–
52	23.08 ± 2.22	D-AVF(−)	***	ns	ns	–	ns
56	23.11 ± 2.76	D-AVF(+)	***	ns	–	ns	ns
10	31.66 ± 4.76	P-AVF(−)	ns	–	ns	ns	*
34	44.7 ± 3.21	P-AVF(+)	–	ns	***	***	***

p Values were multiplicity-corrected.